المؤلفون: Shenglei Li, Yandan Ren, Fanghua Gong, Mengyin Zhang, Wen Zhao, Xiao-Jing Shi, Guiqin Hou, Zhaoming Lu, Yang Wang, Bin Yu, Jianying Zhang, Yan Li

المصدر: Acta Pharmaceutica Sinica. B
Acta Pharmaceutica Sinica B, Vol 10, Iss 6, Pp 1004-1019 (2020)

مصطلحات موضوعية: Original article, Cell cycle checkpoint, AKT, protein kinase B (PKB), IC50, half maximal inhibitory concentration, mTORC1, mTOR, mammalian target of rapamycin, pp242, medicine.disease_cause, mTORC2, TUNEL, terminal deoxynucleotidyl transferase dUTP nick end labeling, 4EBP-1, E binding protein-1, 03 medical and health sciences, 0302 clinical medicine, PI3K, phosphatidylinositol 3 kinase, In vivo, Esophageal squamous cell carcinoma, Medicine, General Pharmacology, Toxicology and Pharmaceutics, Protein kinase B, RAD001, 030304 developmental biology, 0303 health sciences, business.industry, H&E staining, hematoxylin and eosin staining, AKT, lcsh:RM1-950, mTORC2, mTOR complex 2, rapalogs, rapamycin and its analogs, TNM, tumor-node-metastasis, FDA, U.S. Food and Drug Administration, lcsh:Therapeutics. Pharmacology, RICTOR, rapamycin-insensitive companion of mTOR, Apoptosis, 030220 oncology & carcinogenesis, Cancer research, Phosphorylation, p70S6K, p70 ribosomal S6 kinase-1, ESCC, esophageal squamous cell carcinoma, mTORC1, mTOR complex 1, business, Carcinogenesis, RICTOR

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2c1b59250e93bdc4a29506776673a67
https://pubmed.ncbi.nlm.nih.gov/32642408

المؤلفون: Lu Z; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.; Collaborative Innovation Center of Cancer Chemoprevention, Zhengzhou 450001, China., Shi X; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China., Gong F; School of Pharmacy, Wenzhou Medical University, Wenzhou 325035, China., Li S; The First Affiliated Hospital, Zhengzhou University, Zhengzhou 450052, China., Wang Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China., Ren Y; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China., Zhang M; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China., Yu B; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China., Li Y; Center of Advanced Analysis & Gene Sequencing, Zhengzhou University, Zhengzhou 450001, China., Zhao W; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China., Zhang J; Henan Academy of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450052, China., Hou G; School of Pharmaceutical Sciences, Zhengzhou University, Zhengzhou 450001, China.

المصدر: Acta pharmaceutica Sinica. B [Acta Pharm Sin B] 2020 Jun; Vol. 10 (6), pp. 1004-1019. Date of Electronic Publication: 2020 Jan 26.

نوع المنشور: Journal Article

بيانات الدورية: Publisher: Elsevier Country of Publication: Netherlands NLM ID: 101600560 Publication Model: Print-Electronic Cited Medium: Print ISSN: 2211-3835 (Print) Linking ISSN: 22113835 NLM ISO Abbreviation: Acta Pharm Sin B Subsets: PubMed not MEDLINE